Throughout 2022, Rutgers Cancer Institute of New Jersey, the state’s leading cancer program and only National Cancer Institute–designated Comprehensive Cancer Center, together with RWJBarnabas Health, conducted groundbreaking research, provided innovative clinical trials, expanded its multidisciplinary team of highly specialized and internationally-known cancer experts, and celebrated milestones including a topping off ceremony for the Jack and Sheryl Morris Cancer Center, the state’s first freestanding cancer hospital. We reflect on these advancements and look forward to a fruitful 2023. Click here for a full selection of our milestones and research discoveries this past year. |